Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs

被引:2
|
作者
Castro, Catarina [1 ,4 ]
Marta, Ana [1 ,2 ]
Marques, Joao H. [1 ]
Ferreira, Andre [1 ,3 ]
Jose, Diana [1 ]
Sousa, Paulo [1 ]
Neves, Isabel [1 ]
Meneres, Maria Joao [1 ,2 ]
Barbosa, Irene [1 ,2 ]
机构
[1] Univ Porto, Ctr Hosp Univ St Antonio, Dept Ophthalmol, Porto, Portugal
[2] Univ Porto, Inst Biomed Sci Abel Salazar, Dept Ophthalmol, Porto, Portugal
[3] Univ Porto, Dept Biomed, Unit Anat, Fac Med, Porto, Portugal
[4] Ctr Hosp Univ Porto, Dept Ophthalmol, P-4099001 Porto, Portugal
关键词
glaucoma; ocular surface; dry eye disease; QUALITY-OF-LIFE; DRY EYE SYNDROME; INTRAOCULAR-PRESSURE; DISEASE;
D O I
10.1097/IJG.0000000000002272
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis: In this study, patients with glaucoma undergoing topical antihypertensive (TAH) drugs had changes in the ocular surface and more dry eye symptoms than controls. Clinicians should recognize the influence of TAH drops on exacerbating ocular surface disease.Purpose: The purpose of this study was to evaluate the ocular surface of eyes with glaucoma treated with TAH drugs.Methods: Cross-sectional study that included eyes undergoing TAH drugs due to primary open angle glaucoma and controls. The parameters evaluated were: the basal tear flow (basic secretion test); the tear film osmolarity (TearLab); and the noninvasive break-up time, blink score, lipid layer thickness, tear meniscus height, and loss area of the meibomian glands, measured with the IDRA Ocular Surface Analyser. Presence of symptoms [Ocular Surface Disease Index (OSDI)], dry eye disease (DED, TFOS DEWS II criteria), and corneal fluorescein staining were assessed.Results: We included 154 eyes (154 patients), 77 undergoing TAH drugs for glaucoma (group 1) and 77 of controls (group 2). The tear film osmolarity (P=0.003) and the loss area of the meibomian glands (P=0.004) were higher in group 1. The noninvasive break-up time (P=0.005), lipid layer thickness (P=0.006), and tear meniscus height (P=0.001) were lower in group 1. The global OSDI score (P<0.001), the proportion of eyes with severe disease (P=0.002), according to the OSDI, and with DED (P<0.001), according to the TFOS DEWS II criteria, were higher in group 1. The proportion of patients with corneal fluorescein staining was higher in group 1 (P<0.001). There were no significant differences in eyes taking TAH drugs with and without preservatives (P>0.127).Conclusions: DED, in patients with glaucoma, is a multifactorial disease, with a strong contribution from TAH drugs. These eyes had changes in almost every measured parameter, translating into the presence of more dry eye symptoms and corneal damage when compared with controls.
引用
收藏
页码:E113 / E120
页数:8
相关论文
共 50 条
  • [31] Ocular Surface Disease in Patients with Ocular Hypertension and Glaucoma
    Stewart, William C.
    Stewart, Jeanette A.
    Nelson, Lindsay A.
    CURRENT EYE RESEARCH, 2011, 36 (05) : 391 - 398
  • [32] Stress and Allostatic Load in Patients With Primary Open Angle Glaucoma
    Gc, Kiran
    Mahalingam, Karthikeyan
    Gupta, Vivek
    Angmo, Dewang
    Gupta, Shikha
    Dada, Tanuj
    JOURNAL OF GLAUCOMA, 2024, 33 (02) : 87 - 93
  • [33] Ocular surface changes in patients treated with oral antidiabetic drugs or insulin
    Cakir, Burcin Koklu
    Katircioglu, Yasemin
    Unlu, Nurten
    Duman, Sunay
    Ustun, Huseyin
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (04) : 303 - 306
  • [34] Dynamic Scheimpflug Ocular Biomechanical Parameters in Untreated Primary Open Angle Glaucoma Eyes
    Miki, Atsuya
    Yasukura, Yuichi
    Weinreb, Robert N.
    Maeda, Naoyuki
    Yamada, Tomomi
    Koh, Shizuka
    Asai, Tomoko
    Ikuno, Yasushi
    Nishida, Kohji
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (04)
  • [35] Survival of medical treatment success in primary open-angle glaucoma and ocular hypertension
    Fu, Dun Jack
    Ademisoye, Ebenezer
    Shih, Vanessa
    McNaught, Andrew Ian
    Khawaja, Anthony
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024, 108 (12) : 1701 - 1707
  • [36] Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
    Geyman, Lawrence S.
    Suwan, Yanin
    Garg, Reena
    Field, Matthew G.
    Krawitz, Brian D.
    Mo, Shelley
    Pinhas, Alexander
    Ritch, Robert
    Rosen, Richard B.
    JOURNAL OF GLAUCOMA, 2018, 27 (07) : 592 - 599
  • [37] Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma
    Tomic, Martina
    Kastelan, Snjezana
    Soldo, Kata Metez
    Salopek-Rabatic, Jasminka
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [38] Is primary open-angle glaucoma an ocular manifestation of systemic disease?
    Stephanie Wey
    Sarah Amanullah
    George L. Spaeth
    Melih Ustaoglu
    Kamran Rahmatnejad
    L. Jay Katz
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 665 - 673
  • [39] Ocular pulse amplitude in normal tension and primary open angle glaucoma
    Stalmans, Ingeborg
    Harris, Alon
    Vanbellinghen, Veerle
    Zeyen, Thierry
    Siesky, Brent
    JOURNAL OF GLAUCOMA, 2008, 17 (05) : 403 - 407
  • [40] Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension
    Konstas, Anastasios G. P.
    Quaranta, Luciano
    Katsanos, Andreas
    Riva, Ivano
    Tsai, James C.
    Giannopoulos, Theodoros
    Voudouragkaki, Irini C.
    Paschalinou, Eleni
    Floriani, Irene
    Haidich, Anna-Bettina
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (12) : 1510 - 1515